CA3281270A1 - Methods for preparing crystalline peptide inhibitors of interleukin-23 receptor - Google Patents

Methods for preparing crystalline peptide inhibitors of interleukin-23 receptor

Info

Publication number
CA3281270A1
CA3281270A1 CA3281270A CA3281270A CA3281270A1 CA 3281270 A1 CA3281270 A1 CA 3281270A1 CA 3281270 A CA3281270 A CA 3281270A CA 3281270 A CA3281270 A CA 3281270A CA 3281270 A1 CA3281270 A1 CA 3281270A1
Authority
CA
Canada
Prior art keywords
interleukin
receptor
methods
peptide inhibitors
preparing crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3281270A
Other languages
French (fr)
Inventor
David T. Breslin
Geraldine BROECKX
Clara Anduix CANTO
Christopher Paul DE DOBBELAERE
Gildas DENIAU
Giustino Di Pretoro
Philippe Fernandes
Ruzica Kolakovic
Nathalie MERTENS
Sejal Patel
Betty Lomstein Pedersen
Gopal Rajan
Dajun SUN
Brecht DE FRÉ
Dirk Marie A HOEBEN
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of CA3281270A1 publication Critical patent/CA3281270A1/en
Pending legal-status Critical Current

Links

CA3281270A 2023-01-31 2024-01-31 Methods for preparing crystalline peptide inhibitors of interleukin-23 receptor Pending CA3281270A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63/482,512 2023-01-31
US63/517,307 2023-08-02

Publications (1)

Publication Number Publication Date
CA3281270A1 true CA3281270A1 (en) 2024-08-08

Family

ID=

Similar Documents

Publication Publication Date Title
AU2021383828A9 (en) Compositions of peptide inhibitors of interleukin-23 receptor
EP4247403A4 (en) Compositions of peptide inhibitors of interleukin-23 receptor
IL310061A (en) Lipidated peptide inhibitors of interleukin-23 receptor
EP4219473A4 (en) Crystal type ii of malanocortin receptor agonist compound and method for preparing same
HK40131057A (en) Methods for preparing crystalline peptide inhibitors of interleukin-23 receptor
CA3281270A1 (en) Methods for preparing crystalline peptide inhibitors of interleukin-23 receptor
CA3293174A1 (en) Peptide inhibitors of interleukin-23 receptor
CA3279768A1 (en) Peptide inhibitors of interleukin-23 receptor
CA3279774A1 (en) Peptide inhibitors of interleukin-23 receptor
CA3279772A1 (en) Lipidated peptide inhibitors of interleukin-23 receptor
HK40111226A (en) Lipidated peptide inhibitors of interleukin-23 receptor
CA3279924A1 (en) Polycyclic peptide inhibitors of interleukin-23 receptor
CA3279770A1 (en) Formulations of lipidated peptide inhibitors of interleukin-23 receptor
AU2024281784A1 (en) (hetero)aryl-carbonyl-heterobicyclic compounds as inhibitors of pms2 for cancer and degenerative illnesses
HK40101100A (en) Compositions of peptide inhibitors of interleukin-23 receptor
EP4169062A4 (en) Method for nucleation of conductive nitride films
GB202202880D0 (en) Methods for peptide synthesis
CA3283566A1 (en) Crystalline form of midazolam hydrochloride
HK40082084A (en) Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk5
AU2022902386A0 (en) Methods of inhibiting transmembrane proteins
CA3296083A1 (en) Preparation method of crystalline psicose
HK40126897A (en) Phthalazine derivatives useful as inhibitors of nod-like receptor protein 3
HK40108363A (en) Crystallization process of gnrh receptor antagonist
MX2025008922A (en) Methods for preparing crystalline peptide inhibitors of interleukin-23 receptor
CA3307619A1 (en) Processes for preparing kras inhibitors